These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4381952)

  • 1. The role of dopamine in motor excitation of mice induced by brain catecholamine releasers.
    Graeff FG
    J Pharm Pharmacol; 1966 Sep; 18(9):627-8. PubMed ID: 4381952
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

  • 4. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 5. Emetic effect of biogenic amines.
    Cahen RL
    Res Clin Stud Headache; 1970; 3():227-44. PubMed ID: 4144415
    [No Abstract]   [Full Text] [Related]  

  • 6. Contrasting locomotor effects of catecholamine releasers and tyrosine hydroxylase inhibitors in MAO-inhibited mice.
    Weissman A; Koe BK
    Psychopharmacologia; 1967 Aug; 11(3):282-6. PubMed ID: 6055527
    [No Abstract]   [Full Text] [Related]  

  • 7. Metatyrosine as a tool for selective protection of catecholamine stores against reserpine.
    Carlsson A; Lindqvist M
    Eur J Pharmacol; 1967 Dec; 2(3):187-92. PubMed ID: 5590341
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine oxidase and cerebral uptake of dopaminergic drugs.
    Cotzias GC; Tang LC; Ginos JZ
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2715-9. PubMed ID: 4137067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Sachs C
    Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthesis, pharmacological properties and effect upon monoamine oxidase activity of some sydnoneimines].
    Iashunskiĭ VG; Mashkovskiĭ MD; Gorkin VZ; Kholodov LE; Al'tshuler RA; Polezhaeva AI; Verevkina IV
    Farmakol Toksikol; 1970; 33(3):297-302. PubMed ID: 5453024
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 12. [Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors].
    Hassler R; Bak IJ
    Nervenarzt; 1966 Nov; 37(11):493-8. PubMed ID: 5983176
    [No Abstract]   [Full Text] [Related]  

  • 13. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
    Strömbom U
    Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological studies on the brain mechanisms underlying two forms of behavioral excitation: stereotyped hyperactivity and "rage".
    Randrup A; Munkvad I
    Ann N Y Acad Sci; 1969 Jul; 159(3):928-38. PubMed ID: 4902868
    [No Abstract]   [Full Text] [Related]  

  • 15. Storage and synthesis of norepinephrine in the reserpine-treated rat brain.
    Glowinski J; Iversen LL; Axelrod J
    J Pharmacol Exp Ther; 1966 Mar; 151(3):385-99. PubMed ID: 4380046
    [No Abstract]   [Full Text] [Related]  

  • 16. Some aspects of the mechanism of action of various stimulant amphetamine analogues.
    Scheel-Krüger J
    Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulations of brain amines and dopaminergic behavior by a novel, reversible and selective MAO-B inhibitor.
    Mishra N; Sasmal D
    Brain Res; 2012 Aug; 1470():45-51. PubMed ID: 22765918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methyldopa and related agents on pressor responses to tyramine in reserpine-pretreated rats and dogs.
    Torchiana ML; Wenger HC; Stavorski J; Ludden CT; Stone CA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):242-52. PubMed ID: 5932601
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of central monoamines in decapitation convulsions of mice.
    Kamat UG; Sheth UK
    Neuropharmacology; 1971 Sep; 10(5):571-9. PubMed ID: 4399542
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Pharmacology of the adrenergic mechanism.
    Pfeifer AK
    J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4135935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.